Table 1.

HIV Prevalence and Incidence in Key Populations in Thailand, China, Myanmar, and India

	HIV prevalence				HIV incidence
	MSM	TG	PWID	FSW	MSM	TG	PWID	FSW	References
Thailand
Nationwide	5.5–28.3% (2003–2007)	12.5% (2000–2011)		11.9% (2007–2011)	8.2% (2006–2008)				6,8,10,75
Bangkok	30.8% (2007)		23.6% (2013)	22.7% street based; 2.5% venue based (2007)	6.4% (2005) 1.95% (2008–2009)		0.68% (2010)		6,13,143,175
	21.3% (2011)				7.7% (2007) 5.9% (2011)				7
					2.7% (60% were MSM) 2006–2007				23
Chiang Mai	16.9% (2007)		10.9% (2013)						75,175
	16.5–6.9% in bisexuals (2011)	9.30% (2011)			8.2% (2011)				75
Bangkok, Ubon, Ratchathani, Lampang, Mahasarakam					6.3% (2014)				Nittaya Phanuphak, unpublished data
Pattaya					7.4% (2014)	5% (2014)		0.83% (2014)	Merlin Robb, personal communication
Myanmar
Nationwide	7.8% (2011)			18.4% (2008) 9.4% (2012)					12,77
Yangon	5% (2011)
Mandalay	9% (2011)
Pathein				15% (2012)					10,12
China
Nationwide	7.4% (2.3–11.4) (2009)								84
	6% (2010)		9% (2010)	0.36% (2010)			0.57% (2010)	0.02% (2010)	81
	4.9–18% (2008–2009)								85
Beijing	7.8% (2010)				1.7% (2010)				96
Study in 16 cities	5.3% (2009)								94
India
Nationwide	4.4% (2011)		7.1% (2011)	2.7% (2011)					12
Maharashtra		19% (2012)							15
Study in 12 cities	7% (2012–2013)				0.87% (2012–2013)				105
Study in 15 cities			18.1% (2013)				2.9% (2013)		100

This table focuses on the most recent available data in selected countries and key populations where prevention intervention efficacy trials might be considered. Empty cells correspond to no data available. Data in italics correspond to potential target populations suitable for HIV vaccine trials.